U.S. regulators approve new COVID-19 vaccine option
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.—and one that’s already available in Europe and multiple other countries.
Health Care
Articles
Pandemic fueled surge in superbug infections, deaths, CDC says
The surge reversed years of progress fighting one of the gravest public health challenges in modern medicine, according to a new analysis released Tuesday by the Centers for Disease Control and Prevention.
Latest variant driving new wave of coronavirus infections
Officials warn of a possible fall or winter wave—perhaps as many as 100 million infections in the United States—that could again flood hospitals with COVID patients.
Pfizer says tweaked COVID-19 shots boost omicron protection
The FDA is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another COVID surge expected this fall and winter.
COVID-19 vaccines saved 20M lives in 1st year, scientists say
The researchers used data from 185 countries to estimate that vaccines prevented 4.2 million COVID-19 deaths in India, 1.9 million in the United States, 1 million in Brazil, 631,000 in France and 507,000 in the United Kingdom.
Holcomb’s former health care adviser takes job lobbying for nursing home industry
Paul Peaper starts July 1 as president of the Indiana Health Care Association, which represents more than 485 long-term and post-acute care facilities across the state.
Moderna says updated COVID shot boosts omicron protection
COVID-19 vaccine makers are studying updated boosters that might be offered in the fall to better protect people against future coronavirus surges.
Goodman Campbell computer network attacked by hackers
The computer network of Goodman Campbell Brain and Spine, a large, independent surgical group based in Carmel, has been hacked, compromising patient and employee data.
Pfizer seeks authorization of coronavirus shot for children under 5
The advance toward a vaccine for infants, toddlers and preschoolers has been an achingly slow and incremental process, with pediatricians and families waiting for an opportunity to vaccinate young children.
Gridlock could delay more COVID funds until fall, or longer
Administration officials say they’re running low on money to stock up on, or even begin to order, the latest vaccines, tests and treatments. Also lacking are funds to reimburse doctors treating uninsured patients and to help poor countries control the pandemic.
U.S. making COVID antiviral drug more available at test sites
Despite a nationwide surge in COVID-19 cases, deaths from the virus have remained largely stable over the past eight weeks.
Vaccines might not prevent many symptoms of long COVID, study suggests
This week, the Centers for Disease Control and Prevention released new estimates of the syndrome’s toll in the United States, suggesting it affects one in five adults younger than 65 who had COVID, and one in four of those aged 65 and older.
FDA clears COVID booster shot for healthy children ages 5-11
There is one more hurdle: The Centers for Disease Control and Prevention must decide whether to formally recommend the booster for this age group. The CDC’s scientific advisers are scheduled to meet on Thursday.
U.S. deaths from COVID reach 1 million
The U.S. is averaging about 300 COVID-19 deaths per day, compared with a peak of about 3,400 a day in January 2021.
White House warning: U.S. ‘vulnerable’ to COVID without new shots
White House COVID-19 coordinator Dr. Ashish Jha issued a dire warning Thursday that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn’t swiftly approve new funding for more vaccines and treatments.
Museum seeks recollections of Central State Mental Hospital
Memories of patients, staff members and neighbors of Central State Mental Hospital are being compiled for a digital archive.
Pandemic gets tougher to track as COVID testing plunges
Experts say testing has dropped by 70% to 90% worldwide from the first quarter to the second quarter this year—the opposite of what they say should be happening with new omicron variants on the rise in places such as the United States and South Africa.
FDA restricts J&J’s COVID-19 vaccine due to blood clot risk
The vaccine was initially considered an important tool in fighting the pandemic because it required only one shot. But the single-dose option proved less effective than two doses of the Pfizer and Moderna vaccines.
New omicron subvariant shows virus mutations aren’t slowing down
Two-and-a-half years after it first spilled into humans, the COVID virus has repeatedly changed its structure and chemistry in ways that confound efforts to bring it fully under control.
COVID deaths no longer overwhelmingly among unvaccinated as toll on elderly grows
The pandemic’s toll is no longer falling almost exclusively on those who chose not to get shots, with vaccine protection waning over time and the elderly and immunocompromised having a harder time dodging increasingly contagious strains.